A method, system, terminal, and storage medium for evaluating the efficacy of intestinal microbiota transplantation.
By sequencing and bioinformatics analysis of fecal samples from children with autism spectrum disorder, combined with mathematical models to evaluate the efficacy of gut microbiota transplantation, the problem of inaccurate evaluation results was solved, and objective efficacy evaluation of young children was achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHENZHEN CHILDRENS HOSPITAL
- Filing Date
- 2025-12-31
- Publication Date
- 2026-05-26
AI Technical Summary
In existing technologies, the assessment of the efficacy of enterobiota transplantation is easily affected by the assessor's subjective perception and the child's immediate condition. This is especially true for young children or children with autism spectrum disorder who have low cooperation levels, resulting in inaccurate assessment results and making the procedure difficult to implement.
By obtaining fecal samples from affected children, sequencing and preprocessing were performed to determine the relative abundance changes of gut microbiota markers. Random forest regression or support vector regression models were used to assess the efficacy and generate objective efficacy evaluation results.
It enables objective and quantitative assessment of the efficacy of intestinal microbiota transplantation, reduces subjective bias, improves the comparability and reproducibility of assessment results, and expands the coverage of the applicable population, especially young children.
Smart Images

Figure CN122090940A_ABST